Exemptia 40mg Injection

Adalimumab 40mg Injection decreases the levels of acute-phase reactant proteins of inflammation (C­ reactive protein [CRP] and erythrocyte sedimentation rate [ESR]) and serum cytokines (IL-6) and it was compared to baseline in patients diagnosed with rheumatoid arthritis. In patients diagnosed with Crohn’s disease, a decreased level of CRP was also observed in them. Serum levels of matrix metalloproteinases (MMP-1 and MMP-3) that lead to the tissue remodeling responsible for cartilage destruction were also found to be decreased after administering adalimumab in patients, reduction in signs and symptoms of disease, the induction of clinical response, and inhibition of structural damage, and improvements in physical function in adult and pediatric patients with various inflammatory conditions have been demonstrated.

Following are the possible side effects that can occur during your treatment with Adalimumab 40mg injection. Contact your medical practitioner immediately if any of the above-mentioned side effects appear.

Nausea
Injection site reactions
Headache
Back pain
Vomiting
Numbness
Muscle pain
Irregular heartbeat
Bruising
Itching
Ear congestion
Black or tarry stools
Sleep disturbances
Upper respiratory tract infection
Difficulty in breathing ​

Adalimumab 40mg injection should be administered by a qualified nurse or medical professional and recommended dosage is decided by your doctor according to your medical history and current health conditions.

In case of an overdose of Adalimumab, contact your medical practitioner immediately to avoid severe side effects.

​

If you miss a dose of Adalimumab injection, contact your health professional as soon as possible. Try not to miss or skip your dosage of Exemptia injection.